Mike Margolies is the founder of Psychedelic Seminars.
December 12, 2018
Comedian Shane Mauss and Zendo Project's Ryan Beauregard on psychedelic-induced psychosis. “It was really easy once I got past the big video game, ‘Truman Show’ feeling, to get to a place of, ‘oh, that was all in my head. I was crazy.’"
December 21, 2018
Trump signed into law the First Step Act, which makes modest reforms that ease the federal prison population.
January 14, 2019
What does the future hold for MDMA? We explore MAPS' ongoing FDA phase 3 clinical trials, rescheduling, health insurance, and expanded access.
January 16, 2019
What does MDMA rescheduling mean for the recreational user? If you are under the impression that MDMA is on its way to being rescheduled, across the board, you may be disappointed.
January 24, 2019
Until MDMA-assisted psychotherapy is proven without a doubt to reduce long-term costs, many insurance companies do not have an incentive to cover it.
February 4, 2019
As psychedelic medicalization and the potential profits of a “virgin market” loom large, new organizations are increasingly looking to gain legitimacy within the field. Mainstreaming means the doors of this field are being thrown wide open.
February 8, 2019
The Multidisciplinary Association for Psychedelic Studies (MAPS) submitted their MDMA PTSD expanded access protocol to the FDA on January 14, 2019.
March 3, 2019
Eight staff have quit The Third Wave and issued an open statement.
March 6, 2019
After the murder of a Peruvian healer in 2018, traditional healers, local political figures, and nonprofit allies gathered to address the complexities that come with the influx of foreigners seeking ayahuasca in the Amazon.
March 28, 2019
If we truly believe in the positive transformational power of visionary plant experiences, we must support each other to make real social change happen, less this transformation stagnates at the individual level.